Statement by CHPA in Response to FDA’s Proposed Sunscreen Rule

Share page:

Press Releases and Statements | Feb 21, 2019

Today, the Consumer Healthcare Products Association (CHPA) provided the following statement in response to the U.S. Food and Drug Administration’s (FDA) Proposed Rule on Sunscreen Drug Products for Over-the-Counter Human Use:

“FDA is clear that sunscreens contribute substantial public health benefits and that Americans should continue to use currently marketed sunscreens confidently while this important rulemaking effort moves forward.”

 “Sunscreen manufacturers and FDA are aligned on the goal of protecting the public from the harmful effects of the sun. Sunscreens save lives, that’s why millions of Americans use sunscreen products on a daily basis, relying on them to protect their health and the health of their families. We look forward to submitting comments and continuing the dialogue with FDA to reinforce the safety and efficacy of sunscreens.”

The Consumer Healthcare Products Association (CHPA), founded in 1881, is the national trade association representing the leading manufacturers and marketers of consumer healthcare products, including over-the-counter (OTC) medicines, dietary supplements, and consumer medical devices. CHPA is committed to empowering self-care by ensuring that Americans have access to products they can count on to be reliable, affordable, and convenient, while also delivering new and better ways to get and stay healthy. Visit www.chpa.org.